(b)(4).The reported patient effects of hypersensitivity, fever and angina are listed in the xience prime everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.There is no indication that the device caused or contributed to the patient effects.Although a conclusive cause for the reported patient effects and the relationship to the device if any cannot be determined, there is no indication of a product quality deficiency with respect to manufacture, design, or labeling.
|
It was reported that the procedure on (b)(6) 2013 was to treat a lesion located in the right coronary artery with a 2.5x23 mm xience prime stent and the intervention was successful.On (b)(6) 2013, the patient presented with chest pain, fever and a transient, non localized rash.Despite switching antiplatelet medication, the symptoms are continuing.No additional information was provided.
|